Food delivery aggregator Zomato has approved and authorised the opening of its qualified institutional placement (QIP), ...
Flipkart's rejection of the return, citing its 'no return policy', was deemed an unfair trade practice by the consumer court ...
AstraZeneca Pharma India said that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Olaparib film-coated tablets 100 mg & 150 mg (Lynparza ...
ShareChat is expecting EBITDA losses for FY25 to be nearly one-third of FY24 and the consolidated business to start ...
The sharp drop in C2C Advanced Systems' IPO GMP follows SEBI’s intervention after receiving a complaint from an investor.
The Realme GT 7 Pro has finally made its way into the Indian market, with some promising specifications and India's first ...
ShareChat reports a 67% decline in adjusted EBITDA losses to Rs 793 crore in FY24, with revenue growth of 33%. The company is on track for cash breakeven by March 2025 and exploring an IPO in the next ...